Tumor angiogenesis

Head and Neck

Volumn 18, Issue 3, 1996, Pages 283-291

  Petruzzelli, Guy J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; GROWTH FACTOR; HEPARAN SULFATE; MITOGENIC AGENT; POLYPEPTIDE;

ANGIOGENESIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0029864340     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199605/06)18:3<283::aid-hed11>3.0.co;2-c     Document Type: Review

References (53)

1. Folkman J, Cotran RS. Relation of vascular proliferation of tumor growth. Int Rev Exp Path 1976;16:207-248.
2. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275-288.
3. Folkman J. Tumor angiogenesis. In Becker FF, ed. Cancer: a comprehensive tretise. New York: Plenum Press, 1975:355-388.
4. 3a. Eisenstein R, Sorgente N, Soble L, Miller A, Kuettner KE. The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol 1973;73:765-774.
5. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Nat Cancer Inst 1990;82:4-6.
6. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
7. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
8. Gimbrone MA, Cotran RS, Folkman J. Tumor growth neovascularization: an experimental model using rabbit cornea. J Natl Cancer Inst 1974;52:413-427.
9. Hori A, Sasada R, Matsutani, et al. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 1991;51:6180-6184.
10. Magsbrun M, Knighton D, Folkman J. Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res 1976;36:110-119.
11. Folkman J. Tumor angiogenesis factor. Cancer Res 1984;34:2109-2113.
12. Hayek A, Culler FL, Beattie GM, Lopez AD, Cuevas P, Baird A. An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Com 1987;147:876-880.
13. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochem Biophys Acta 1990;1032:89-118.
14. Dusseau JW, Hutchins PM, Malbasa DS. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res 1986;59:163-170.
15. Klagsbrun M, Folkman J. Angiogenesis. In Sporn MB, Roberts AB, eds. Handbook of experimental pharmacology, vol. 95 part 1. Peptide growth factors and their receptors. New York: Springer Verlag, 1990.
16. 14a. Stokes CL. Endothelial cell migration and chemotaxis in angiogenesis. In Steiner R, Weisz PB, Langer R, eds. Angiogenesis: key principles-science-technology-medicine, Basel: Birkhauser Verlag, 1992:118-124.
17. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;232:442-447.
18. Furcht LT. Critical factors controling angiogenesis: cell products, cell matrix and growth factors. Lab Invest 1986;55:505-509.
19. Presta M, Rifkin DB. New aspects of blood vessel growth-tumor and tissue-derived angiogenesis factors. Haemostasis 1988;18:6-17.
20. Srivastava A, Laidler P, Davies R, et al. The prognostic significance of tumor vascularity in intermediate-thickness skin melanoma. Am J Pathol 1986;133:419-423.
21. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation with invasive breast carcinoma. N Engl J Med 1991;324:1-7.
22. Weidner N, Folkman J, Pozza et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
23. Bosari S, Lee AKC, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761.
24. Macchiarini P, Fontaini G, Hardin MJ, et al. Relation of neovasculature to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
25. Wakui S, Furusato M, Itch T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992;168:257-262.
26. Weidner N. Tumor angiogenesis: a review of current applications in tumor prognostication. Semin Diagn Pathol 1993;10:302-313.
27. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
28. Petruzzelli GJ, Synderman CH, Johnson JT. Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embyro squamous cell carcinoma model. Ann Otol Rhinol Laryngol 1993;102:215-221.
29. Taitz A, Petruzzelli GJ, Lozano Y, Shankar R, Young MRI. Bidirectional stimulation of adherence to extracellular matrix components by human head and neck squamous cell carcinoma cells and endothelial cells. Cancer Letters 1995;96:253-260.
30. Thomas GR, Tubb EE, Sessions RB, Cullen KJ. Growth factor mRNA expression in human head and neck malignant tumors. Arch Otolaryngol Head Neck Surg 1993;119:1247-1252.
31. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, et al. Intratumoral microvessel density and the p53 protein: correlation with metastasis in head and neck squamous cell carcinoma. Int J Cancer 1993;55:739-744.
32. Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg 1994;111:417-422.
33. Kinsella JB, Kumar D, Rassekh CR, Bailey BJ. Angiogenesis by microvascular quantitation and prognosis in supraglottic carcinoma. Otolaryngol Head Neck Surg 1995;108:84.
34. Williams JK, Carlson GW, Cohen G, Derose PB, Hunter S, Jurkiewicz MJ. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994;168:373-380
35. 32a. Albo D, Granick MS, Jhala N, Atkinson B, Solomon MP. The relationship of angiogenesis to biological activity in human squamous cell carcinoma of the head and neck. Ann Plast Surg 1994;32:588-592.
36. Folkman J, Ingber DE. Inhibitors of angiogenesis. Semin Cancer Biol 1992;3:89-96.
37. Folkman J. Successful treatment of an angiogenic disease (Editorial). N Engl J Med 1989;320:1211-1212.
38. Ezekbowitz RA, Mulliken JB, Folkman J. Interferon alpha-2a therapy for life threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-1463.
39. Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagallin that inhibit angiogenesis and suppress tumor growth. Nature 1990;348:555-557.
40. Takamiya Y, Friedlander RM, Brem H, Malick A. Martuza RL. Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. J Neurosurg 1993;470-476.
41. 37a. Folkman J, Ingber DE. Angiostatic steroids. Ann Surg 1987;206:374-383.
42. Lee K, Iwamura M, Cockett ATK. Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice. Cancer Chemother Pharmacol 1990;26:461-463.
43. Li WW, Casey R, Gonzalez EM, Folkman J. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization. Invest Ophth Vis Sci 1991;32:2888-2905.
44. Lauk S, Zietman A, Skates S, Fabian R, Suit HD. Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. Cancer Res 1989;49:4557-4561.
45. Teicher BA, Sotomayor EA, Haung ZD. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 1992;52:6702-6704.
46. Gagliardi A, Collins DC. Inhibition of angiogenesis by anti-estrogens. Cancer Res 1993;53:533-535.
47. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 1990;82:848-853.
48. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, et al. Inhibition of angiogenesis by recombinant human platelet facor-4 and related peptides. Science 1990;247:77-79.
49. Kolber DL, Knisely TL, Maione TE. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J Natl Cancer Inst 1995;87:304-309.
50. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis from murine melanoma cells. Science 1986;232:467-470.
51. 2. Cancer Res 1991;51:903-906.
52. Gagliardi A, Hadd H, Collins DC. Inhibition of angiogenesis by suramin. Cancer Res 1992;52:5073-5075.
53. Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Asp BH, Isaacs JT. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res 1993;53:1833-1837.